{"i": ["raltitrexed", "raltitrexed and oxaliplatin", "De Gramont schedule combined with oxaliplatin ( FOLFOX )", "palliative chemotherapy", "best supportive care", "TOMOX", "chemotherapy", "TOMOX combination", "Raltitrexed", "5 - FU or 5 - FU / LV", "oxaliplatin plus", "FOLFOX", "oxaliplatin plus 5FU / LV", "oxaliplatino", "FOLFOX4 or TOMOX .", "oxaliplatin plus 5 - fluorouracil and leucovorin ( FOLFOX4 )", "adjuvant chemotherapy", "leucovorin", "TOMOX or FOLFOX4 .", "raltitrexed and 5 - FU - based chemotherapy", "5 - FU", "oxaliplatin ( TOMOX )", "Prophylactic anti - emetics", "Raltitrexed ( Tomudex \u00ae)", "oxaliplatin plus raltitrexed ( TOMOX )", "bimonthly 5 - FU / leucovorin ( LV )", "5 - FU / LV", "antibodies cetuximab and panitumumab .", "5 - fluorouracil ( 5 - FU )- based chemotherapy", "fluoropyrimidine - based", "Oxaliplatin", "FOLFOX4", "oxaliplatin", "oxaliplatin .", "growth factor antibody bevacizumab"], "o": ["AEs", "progression - free survival", "quality of life ( QoL )", "response rate ( RR ) and PFS", "tolerability", "ORR", "Grades 3 and 4 neutropenia", "peripheral neuropathy", "composite physical health and mental health scores", "median OS", "PD", "thrombocytopenia", "leucopenia", "Quality of life", "mean mental health score", "number of treatment - related deaths .", "median PFS values", "response duration", "SF - 36 scores", "Grades 3 \u2013 4 hematologic AEs", "OS and PFS", "Hepatic disorders", "Overall response rate", "leukopenia", "SF - 36", "OS , PFS , response duration , tolerability and QoL .", "composite physical / mental health measurements", "RR or survival outcomes", "PFS", "body pain and emotional role functioning", "ORRs", "overall response rate", "location of primary tumor", "efficacy and tolerability", "overall survival ( OS ), progression - free survival ( PFS )", "serum terminal half life", "Objective Response Rate ( ORR ).", "number of patients required", "tolerability profile", "survival", "bodily pain", "overall survival", "complete medical history , physical examination , performance status , complete blood count , serum chemistry , electrocardiogram , and baseline measurement of tumor size based on tomography scans ( CT ).", "neurotoxicity , incidence of paresthesias grade", "ORR , PFS and OS", "asthenia", "unacceptable toxicity .", "diarrhea , or stomatitis G2", "neutropenia", "rate of toxic death", "emotional role functioning", "prevalence of rectal tumors", "Tolerability", "toxicity", "incidence of neutropenia and leukopenia grade", "serious AEs ( SAEs ).", "bodily pain and emotional role functioning scores", "neutropenia , thrombocytopenia , diarrhea , stomatitis , or other toxicities", "physical and mental composite scores", "RR , survival and toxicity results", "incidence of hepatic disorders and asthenia", "QoL", "short form - 36 ( SF - 36 ) questionnaire", "non - hematological toxicities", "mean physical health score", "incidence rate of SAEs", "pancitopenia plus septic shock", "number of treatment - related deaths", "safety and tolerability", "tolerated", "neutropenic sepsis", "median relative dose intensity", "components of SF - 36", "composite scores", "safety profiles", "efficacy and safety profile", "leukopenia and mucositis / stomatitis", "Response duration", "toxicities", "hepatic disorders and asthenia", "- related deaths"]}